Invega Hafyera (paliperidone) is a long-acting atypical antipsychotic. It's used to treat adults with schizophrenia. This medication is injected under the skin by a healthcare professional every 6 months. But it's only for people who've already tried and is stable on either the once-monthly injection (Invega Sustenna) or the every-3-month injection (Invega Trinza). Common side effects of Invega Hafyera (paliperidone) include upper respiratory tract infection, pain or swelling around the injection site, and weight gain.
Invega Hafyera (paliperidone) is an atypical antipsychotic. It can affect dopamine and serotonin levels in your brain, which helps control your thoughts, mood, and behaviors.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Schizophrenia in adults
Bipolar I disorder in adults
By providing your email, you consent to receive marketing communications from GoodRx, which may include content and/or data related to men’s health, women's health, reproductive care, or sexual health. You agree to the GoodRx Terms of Use and acknowledge the Privacy Policy. You can unsubscribe at any time.
Janssen Pharmaceuticals, Inc. (2021). Invega Hafyera- paliperidone palmitate injection, suspension, extended release [package insert]. DailyMed.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.